Skip to main content
David Peereboom, MD, Oncology, Cleveland, OH, Cleveland Clinic

DavidM.PeereboomMD

Oncology Cleveland, OH

Neuro-Oncology

Professor of Medicine, Cleveland Clinic College of Medicine; Director, Clinical Research, Brain Tumor and Neuro-Oncology Center

Dr. Peereboom is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Peereboom's full profile

Already have an account?

Summary

  • Dr. David Peereboom is a medical oncologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Virginia Commonwealth University School of Medicine and has been in practice 26 years. He specializes in in neuro-oncology with expertise in primary and metastatic CNS malignancies including primary CNS lymphoma.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1990 - 1993
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1986 - 1989
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1986
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyBS, Chemical Engineering, 1978 - 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2010
  • IL State Medical License
    IL State Medical License 2002 - 2005
  • PA State Medical License
    PA State Medical License 2002 - 2004
  • MI State Medical License
    MI State Medical License 2002 - 2018
  • MD State Medical License
    MD State Medical License 1990 - 1993
  • OH State Medical License
    OH State Medical License 1989 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America�s Best Doctors 2017
  • Cleveland�s Top Doctors 2015
  • America's Top Doctors Castle Connolly, 2010-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Adjuvant chemotherapy in patients with newly diagnosed non-co-deleted anaplastic gliomas�a new standard  
    Braun KL, Peereboom DM, Transl Cancer Res, 1/1/2018
  • Phase 2 trial of SL-701 in relapsed/refractory glioblastoma: Preliminary correlation of immune response with longer-term survival  
    Peereboom DM, Nabors B, Kumthekar P, Badruddoja M, Fink K, Lieberman F, Phuphanich S, Dunbar E, Walbert T, Schiff D, Sherman J, Tran D, Ashby L, Butowski N, Iwamoto F,..., J Clin Oncol, 1/1/2018
  • Adjuvant chemotherapy in patients with newly diagnosed non-co-deleted anaplastic gliomas�a new standard  
    Braun KL, Peereboom DM, Translational Cancer Research, 1/1/2018
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Circulating Endothelial Cells in Recurrent Glioblastoma.
    Stockham A, Borden E, Peereboom DM., Society for Neuro-Oncology Meeting, Orange County, CA, 1/1/2011
  • Ogilvie�s syndrome during chemotherapy of primary central nervous system lymphoma
    Xie H, Peereboom DM., The American College of Physician National Meeting, San Diego, CA, 1/1/2011
  • Primary central nervous system lymphoma: the Cleveland Clinic experience
    Xie H, Peereboom DM., Lepow Research Day, Case Western Reserve University, Cleveland, OH, 1/1/2011
  • Join now to see all

Lectures

  • Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Chemotherapy in Neuro-Oncology: Principles and Practice 
    New Orleans, LA - 1/1/2018
  • Systemic Therapy for Meningiomas 
    Santa Monica, CA - 1/1/2018
  • Join now to see all

Other

  • Audio cast �Update in Brain Tumors� 
    Research to Practice
    Cleveland, OH - 1/1/2010
  • Malignant Glioma Update Think Tank 
    Research to Practice
    Miami, FL - 1/1/2009
  • Current Clinical Research Data on Bevacizumab in High Grade Gliomas 
    Research to Practice
    Miami, FL - 1/1/2009
  • Join now to see all

Authored Content

  • First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018
  • First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018

Press Mentions

  • Living with Rare Brain Cancer: Woman Shares Story on Glioblastoma Awareness Day
    Living with Rare Brain Cancer: Woman Shares Story on Glioblastoma Awareness DayJuly 17th, 2019
  • Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside Initiatives
    Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside InitiativesNovember 2nd, 2018
  • Electricity Helps Control Man’s Brain Tumor
    Electricity Helps Control Man’s Brain TumorAugust 7th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations